BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 15812226)

  • 1. Adenovirus-mediated CD40L gene therapy induced both humoral and cellular immunity against rat model of hepatocellular carcinoma.
    Iida T; Shiba H; Misawa T; Ohashi T; Eto Y; Yanaga K
    Cancer Sci; 2008 Oct; 99(10):2097-103. PubMed ID: 19016771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice.
    Düchs MJ; Kratzer RF; Vieyra-Garcia P; Strobel B; Schönberger T; Groß P; Aljayyoussi G; Gupta A; Lang I; Klein H; Morilla SM; Hopf S; Park J; Kreuz S; Klugmann M; Igney FH
    Front Immunol; 2024; 15():1360063. PubMed ID: 38558809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo.
    Lieschke GJ; Rao PK; Gately MK; Mulligan RC
    Nat Biotechnol; 1997 Jan; 15(1):35-40. PubMed ID: 9035103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized Interleukin-12 for Cancer Immunotherapy.
    Nguyen KG; Vrabel MR; Mantooth SM; Hopkins JJ; Wagner ES; Gabaldon TA; Zaharoff DA
    Front Immunol; 2020; 11():575597. PubMed ID: 33178203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment.
    Wu CJ; Tsai YT; Lee IJ; Wu PY; Lu LS; Tsao WS; Huang YJ; Chang CC; Ka SM; Tao MH
    Oncoimmunology; 2018; 7(9):e1477459. PubMed ID: 30228946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation.
    Knippertz I; Deinzer A; Dörrie J; Schaft N; Nettelbeck DM; Steinkasserer A
    J Immunol Res; 2016; 2016():6078473. PubMed ID: 27446966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model.
    Poutou J; Bunuales M; Gonzalez-Aparicio M; Garcia-Aragoncillo E; Quetglas JI; Casado R; Bravo-Perez C; Alzuguren P; Hernandez-Alcoceba R
    Gene Ther; 2015 Sep; 22(9):696-706. PubMed ID: 25938192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy: regulations, ethics and its practicalities in liver disease.
    Jin X; Yang YD; Li YM
    World J Gastroenterol; 2008 Apr; 14(15):2303-7. PubMed ID: 18416454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering targeted viral vectors for gene therapy.
    Waehler R; Russell SJ; Curiel DT
    Nat Rev Genet; 2007 Aug; 8(8):573-87. PubMed ID: 17607305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of an adenoviral vector for highly efficient and doxycycline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancer.
    Wulff H; Krieger T; Krüger K; Stahmer I; Thaiss F; Schäfer H; Block A
    BMC Biotechnol; 2007 Jun; 7():35. PubMed ID: 17594499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of liver cancer.
    Hernandez-Alcoceba R; Sangro B; Prieto J
    World J Gastroenterol; 2006 Oct; 12(38):6085-97. PubMed ID: 17036377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
    Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
    Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
    J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma.
    Schmitz V; Barajas M; Wang L; Peng D; Duarte M; Prieto J; Qian C
    Hepatology; 2001 Jul; 34(1):72-81. PubMed ID: 11431736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy of cancer based on interleukin 12.
    Sangro B; Melero I; Qian C; Prieto J
    Curr Gene Ther; 2005 Dec; 5(6):573-81. PubMed ID: 16457647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.
    Hernandez-Alcoceba R; Poutou J; Ballesteros-Briones MC; Smerdou C
    Immunotherapy; 2016 Feb; 8(2):179-98. PubMed ID: 26786809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12.
    Waehler R; Ittrich H; Mueller L; Krupski G; Ameis D; Schnieders F
    Hum Gene Ther; 2005 Mar; 16(3):307-17. PubMed ID: 15812226
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.